Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$1.65 - $3.12 $52,531 - $99,331
-31,837 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$2.31 - $5.85 $73,543 - $186,246
31,837 New
31,837 $82,000
Q3 2021

Nov 12, 2021

SELL
$4.55 - $10.36 $66,885 - $152,292
-14,700 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$5.98 - $7.51 $87,906 - $110,397
14,700 New
14,700 $101,000
Q1 2021

May 17, 2021

SELL
$6.98 - $11.29 $72,592 - $117,415
-10,400 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$7.81 - $10.39 $81,224 - $108,056
10,400 New
10,400 $84,000

Others Institutions Holding RDHL

About RedHill Biopharma Ltd.


  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $192M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.